BioCentury | Jul 13, 2015
Clinical News

Sembragiline: Phase IIb data

...The double-blind, international Phase IIb MAyflOwer RoAD trial in about 544 patients with moderate severity AD...
BioCentury | Jul 1, 2015
Clinical News

Sembragiline misses AD endpoint

...primary endpoint in a Phase IIb trial to treat moderately severe Alzheimer's disease. In the MAyflOwer...
BioCentury | Jun 2, 2014
Clinical News

RG1577: Completed Phase IIb enrollment

...disclosed in its 1Q14 earnings that Roche completed enrollment of the placebo-controlled, international Phase IIb MAyflOwer...
BioCentury | Nov 17, 2006
Financial News

Neurotech raises $35 million

...Nexus Medical Partners; and Pound Capital joined existing investors Apax Partners; Merlin Biosciences; Atlas Venture; Mayflower...
BioCentury | Apr 25, 2005
Company News

Penwest board of directors update

...Pharmaceuticals Co. (PPCO), Danbury, Conn. Business: Drug delivery Appointed: Peter Drake, managing general partner of Mayflower...
BioCentury | Nov 10, 2003
Company News

Cortex Pharmaceuticals board of directors update

...Cortex Pharmaceuticals Inc. (COR), Irvine, Calif. Business: Neurology Appointed: Peter Drake, managing general partner of Mayflower...
Items per page:
1 - 6 of 6
BioCentury | Jul 13, 2015
Clinical News

Sembragiline: Phase IIb data

...The double-blind, international Phase IIb MAyflOwer RoAD trial in about 544 patients with moderate severity AD...
BioCentury | Jul 1, 2015
Clinical News

Sembragiline misses AD endpoint

...primary endpoint in a Phase IIb trial to treat moderately severe Alzheimer's disease. In the MAyflOwer...
BioCentury | Jun 2, 2014
Clinical News

RG1577: Completed Phase IIb enrollment

...disclosed in its 1Q14 earnings that Roche completed enrollment of the placebo-controlled, international Phase IIb MAyflOwer...
BioCentury | Nov 17, 2006
Financial News

Neurotech raises $35 million

...Nexus Medical Partners; and Pound Capital joined existing investors Apax Partners; Merlin Biosciences; Atlas Venture; Mayflower...
BioCentury | Apr 25, 2005
Company News

Penwest board of directors update

...Pharmaceuticals Co. (PPCO), Danbury, Conn. Business: Drug delivery Appointed: Peter Drake, managing general partner of Mayflower...
BioCentury | Nov 10, 2003
Company News

Cortex Pharmaceuticals board of directors update

...Cortex Pharmaceuticals Inc. (COR), Irvine, Calif. Business: Neurology Appointed: Peter Drake, managing general partner of Mayflower...
Items per page:
1 - 6 of 6